Skip to main content
Erschienen in: European Journal of Orthopaedic Surgery & Traumatology 1/2015

01.01.2015 | Expert's Opinion (General Review)

State-of-the-art approach for bone sarcomas

verfasst von: Andreas F. Mavrogenis, Andrea Angelini, Christos Vottis, Emanuela Palmerini, Eugenio Rimondi, Giuseppe Rossi, Panayiotis J. Papagelopoulos, Pietro Ruggieri

Erschienen in: European Journal of Orthopaedic Surgery & Traumatology | Ausgabe 1/2015

Einloggen, um Zugang zu erhalten

Abstract

Bone sarcomas are a variety of non-epithelial, malignant neoplasms of bone. The most common bone sarcomas are osteosarcoma, Ewing’s sarcoma, and chondrosarcoma. The approach to a patient with a suspected bone sarcoma from initial examination to the histological diagnosis and classification is staging. Staging is of critical importance, in order to classify different treatment options and point out which combination of them is more suitable depending on the severity of the tumor in every individual patient. Staging should include medical history, physical and imaging examination, and biopsy. This article presents the current approach for staging, principles of biopsy, tumor classification, treatment, and follow-up of patients with bone sarcomas.
Literatur
1.
Zurück zum Zitat Calabrò T, Mavrogenis AF, Ruggieri P (2011) Osteoblastic osteosarcoma in monostotic Paget’s disease. Musculoskelet Surg 95(1):37–40PubMed Calabrò T, Mavrogenis AF, Ruggieri P (2011) Osteoblastic osteosarcoma in monostotic Paget’s disease. Musculoskelet Surg 95(1):37–40PubMed
2.
Zurück zum Zitat Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P (2012) Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res 470(6):1735–1748PubMedCentralPubMed Mavrogenis AF, Abati CN, Romagnoli C, Ruggieri P (2012) Similar survival but better function for patients after limb salvage versus amputation for distal tibia osteosarcoma. Clin Orthop Relat Res 470(6):1735–1748PubMedCentralPubMed
3.
Zurück zum Zitat Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11(5):421–429PubMed Tirode F, Laud-Duval K, Prieur A, Delorme B, Charbord P, Delattre O (2007) Mesenchymal stem cell features of Ewing tumors. Cancer Cell 11(5):421–429PubMed
4.
Zurück zum Zitat Bielack SS, Carrle D (2008) State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol 19(Suppl 7):vii155–vii160PubMed Bielack SS, Carrle D (2008) State-of-the-art approach in selective curable tumors: bone sarcoma. Ann Oncol 19(Suppl 7):vii155–vii160PubMed
5.
Zurück zum Zitat ESMO/European Sarcoma Network Working Group (2012) Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii100–vii109 ESMO/European Sarcoma Network Working Group (2012) Bone sarcomas: ESMO clinical practice guidelines for diagnosis, treatment and follow-up. Ann Oncol 23(Suppl 7):vii100–vii109
6.
Zurück zum Zitat Grimer RJ, Briggs TWR (2010) Earlier diagnosis of bone and soft-tissue tumors. J Bone Joint Surg Br 92-B:1489–1492 Grimer RJ, Briggs TWR (2010) Earlier diagnosis of bone and soft-tissue tumors. J Bone Joint Surg Br 92-B:1489–1492
7.
Zurück zum Zitat Meyer JS, Nadel HR, Marina N et al (2008) Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 51:163–170PubMed Meyer JS, Nadel HR, Marina N et al (2008) Imaging guidelines for children with Ewing sarcoma and osteosarcoma: a report from the Children’s Oncology Group Bone Tumor Committee. Pediatr Blood Cancer 51:163–170PubMed
8.
Zurück zum Zitat Lietman SA, Joyce MJ (2010) Bone sarcomas: overview of management, with a focus on surgical treatment considerations. Clevel Clin J Med 77(Suppl 1):S8–S12 Lietman SA, Joyce MJ (2010) Bone sarcomas: overview of management, with a focus on surgical treatment considerations. Clevel Clin J Med 77(Suppl 1):S8–S12
9.
Zurück zum Zitat Bramer JA, van Linge JH, Grimer RJ et al (2009) Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol 35:1030–1036PubMed Bramer JA, van Linge JH, Grimer RJ et al (2009) Prognostic factors in localized extremity osteosarcoma: a systematic review. Eur J Surg Oncol 35:1030–1036PubMed
10.
Zurück zum Zitat Leavey PJ, Collier AB (2008) Ewing sarcoma: prognostic criteria, outcomes and future treatment. Expert Rev Anticancer Ther 8:617–624PubMed Leavey PJ, Collier AB (2008) Ewing sarcoma: prognostic criteria, outcomes and future treatment. Expert Rev Anticancer Ther 8:617–624PubMed
11.
Zurück zum Zitat Enneking WF (1982) The issue of the biopsy. J Bone Joint Surg Am 64:1119–1120 Enneking WF (1982) The issue of the biopsy. J Bone Joint Surg Am 64:1119–1120
12.
Zurück zum Zitat Andreou D, Bielack SS, Carrle D et al (2011) The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22(5):1228–1235PubMed Andreou D, Bielack SS, Carrle D et al (2011) The influence of tumor- and treatment-related factors on the development of local recurrence in osteosarcoma after adequate surgery. An analysis of 1355 patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. Ann Oncol 22(5):1228–1235PubMed
13.
Zurück zum Zitat van den Berg H, Slaar A, Kroon HM et al (2008) Results of diagnostic review in pediatric bone tumors and tumor-like lesions. J Pediatr Orthop 28:561–564PubMed van den Berg H, Slaar A, Kroon HM et al (2008) Results of diagnostic review in pediatric bone tumors and tumor-like lesions. J Pediatr Orthop 28:561–564PubMed
14.
Zurück zum Zitat Mankin HJ, Lange TA, Spanier SS (1982) The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 64:1121–1127PubMed Mankin HJ, Lange TA, Spanier SS (1982) The hazards of biopsy in patients with malignant primary bone and soft-tissue tumors. J Bone Joint Surg Am 64:1121–1127PubMed
15.
Zurück zum Zitat Mavrogenis AF, Gambarotti M, Angelini A, Palmerini E, Staals EL, Ruggieri P, Papagelopoulos PJ (2012) Chondrosarcomas revisited. Orthopedics 35(3):e379–e390PubMed Mavrogenis AF, Gambarotti M, Angelini A, Palmerini E, Staals EL, Ruggieri P, Papagelopoulos PJ (2012) Chondrosarcomas revisited. Orthopedics 35(3):e379–e390PubMed
16.
Zurück zum Zitat Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO classification of tumours of soft tissue and bone. IARC Press, Lyon Fletcher CDM, Bridge JA, Hogendoorn P, Mertens F (2013) WHO classification of tumours of soft tissue and bone. IARC Press, Lyon
17.
Zurück zum Zitat Picci P, Vanel D, Briccoli A et al (2001) Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 12:1601–1604PubMed Picci P, Vanel D, Briccoli A et al (2001) Computed tomography of pulmonary metastases from osteosarcoma: the less poor technique. A study of 51 patients with histological correlation. Ann Oncol 12:1601–1604PubMed
18.
Zurück zum Zitat Benz MR, Tchekmedyian N, Eilber FC et al (2009) Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol 21:345–351PubMed Benz MR, Tchekmedyian N, Eilber FC et al (2009) Utilization of positron emission tomography in the management of patients with sarcoma. Curr Opin Oncol 21:345–351PubMed
19.
Zurück zum Zitat Moriceau G, Ory B, Mitrofan L, Riganti C, Blanchard F, Brion R, Charrier C, Battaglia S, Pilet P, Denis MG, Shultz LD, Mönkkönen J, Rédini F, Heymann D (2010) Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process. Cancer Res 70(24):10329–10339PubMedCentralPubMed Moriceau G, Ory B, Mitrofan L, Riganti C, Blanchard F, Brion R, Charrier C, Battaglia S, Pilet P, Denis MG, Shultz LD, Mönkkönen J, Rédini F, Heymann D (2010) Zoledronic acid potentiates mTOR inhibition and abolishes the resistance of osteosarcoma cells to RAD001 (Everolimus): pivotal role of the prenylation process. Cancer Res 70(24):10329–10339PubMedCentralPubMed
20.
Zurück zum Zitat Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 204:9–24PubMed Enneking WF (1986) A system of staging musculoskeletal neoplasms. Clin Orthop Relat Res 204:9–24PubMed
21.
Zurück zum Zitat Jawad MU, Scully SP (2010) In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system. Clin Orthop Relat Res 468(7):2000–2002PubMedCentralPubMed Jawad MU, Scully SP (2010) In brief: classifications in brief: enneking classification: benign and malignant tumors of the musculoskeletal system. Clin Orthop Relat Res 468(7):2000–2002PubMedCentralPubMed
22.
Zurück zum Zitat Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC cancer staging manual. Springer, New York, pp 213–219 Greene FL, Page DL, Fleming ID et al (eds) (2002) AJCC cancer staging manual. Springer, New York, pp 213–219
23.
Zurück zum Zitat Campanacci M (1999) Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. Springer, New York, pp 1–70 Campanacci M (1999) Bone and soft tissue tumors: clinical features, imaging, pathology and treatment. Springer, New York, pp 1–70
24.
Zurück zum Zitat Malawer MM, Helman LJ, O’Sullivan B (2004) Sarcomas of bone. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Vol 2, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1794–1893 Malawer MM, Helman LJ, O’Sullivan B (2004) Sarcomas of bone. In: DeVita VT Jr, Hellman S, Rosenberg SA (eds) Cancer: principles and practice of oncology. Vol 2, 7th edn. Lippincott Williams & Wilkins, Philadelphia, pp 1794–1893
25.
Zurück zum Zitat Odri GA, Dumoucel S, Picarda G, Battaglia S, Lamoureux F, Corradini N, Rousseau J, Tirode F, Laud K, Delattre O, Gouin F, Heymann D, Rédini F (2010) Zoledronic acid as a new adjuvant therapeutic strategy for Ewing’s sarcoma patients. Cancer Res 70(19):7610–7619PubMed Odri GA, Dumoucel S, Picarda G, Battaglia S, Lamoureux F, Corradini N, Rousseau J, Tirode F, Laud K, Delattre O, Gouin F, Heymann D, Rédini F (2010) Zoledronic acid as a new adjuvant therapeutic strategy for Ewing’s sarcoma patients. Cancer Res 70(19):7610–7619PubMed
26.
Zurück zum Zitat Lamoureux F, Richard P, Wittrant Y, Battaglia S, Pilet P, Trichet V, Blanchard F, Gouin F, Pitard B, Heymann D, Rédini F (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res 67(15):7308–7318PubMed Lamoureux F, Richard P, Wittrant Y, Battaglia S, Pilet P, Trichet V, Blanchard F, Gouin F, Pitard B, Heymann D, Rédini F (2007) Therapeutic relevance of osteoprotegerin gene therapy in osteosarcoma: blockade of the vicious cycle between tumor cell proliferation and bone resorption. Cancer Res 67(15):7308–7318PubMed
27.
Zurück zum Zitat Lamoureux F, Picarda G, Rousseau J, Gourden C, Battaglia S, Charrier C, Pitard B, Heymann D, Rédini F (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Mol Cancer Ther 7(10):3389–3398PubMedCentralPubMed Lamoureux F, Picarda G, Rousseau J, Gourden C, Battaglia S, Charrier C, Pitard B, Heymann D, Rédini F (2008) Therapeutic efficacy of soluble receptor activator of nuclear factor-kappa B-Fc delivered by nonviral gene transfer in a mouse model of osteolytic osteosarcoma. Mol Cancer Ther 7(10):3389–3398PubMedCentralPubMed
28.
Zurück zum Zitat Duan X, Jia SF, Koshkina N, Kleinerman ES (2006) Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer 106(6):1382–1388PubMed Duan X, Jia SF, Koshkina N, Kleinerman ES (2006) Intranasal interleukin-12 gene therapy enhanced the activity of ifosfamide against osteosarcoma lung metastases. Cancer 106(6):1382–1388PubMed
29.
Zurück zum Zitat Simon MA, Springfield DS (1998) Surgery for bone and soft-tissue tumors. Lippincott-Raven, Philadelphia Simon MA, Springfield DS (1998) Surgery for bone and soft-tissue tumors. Lippincott-Raven, Philadelphia
30.
Zurück zum Zitat Mavrogenis AF, Pala E, Guerra G, Ruggieri P (2012) Post-radiation sarcomas. Clinical outcome of 52 patients. J Surg Oncol 105(6):570–576PubMed Mavrogenis AF, Pala E, Guerra G, Ruggieri P (2012) Post-radiation sarcomas. Clinical outcome of 52 patients. J Surg Oncol 105(6):570–576PubMed
31.
Zurück zum Zitat Mavrogenis AF, Angelini A, Pala E, Calabro T, Bianchi G, Casadei R, Ruggieri P (2011) Radiation-induced sarcomas. J Long Term Eff Med Implants 21(3):233–240PubMed Mavrogenis AF, Angelini A, Pala E, Calabro T, Bianchi G, Casadei R, Ruggieri P (2011) Radiation-induced sarcomas. J Long Term Eff Med Implants 21(3):233–240PubMed
32.
Zurück zum Zitat Picci P, Sangiorgi L, Rougraff BT et al (1994) Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699–2705PubMed Picci P, Sangiorgi L, Rougraff BT et al (1994) Relationship of chemotherapy-induced necrosis and surgical margins to local recurrence in osteosarcoma. J Clin Oncol 12:2699–2705PubMed
33.
Zurück zum Zitat Blakely ML, Spurbeck WW, Pappo AS et al (1999) The impact of margin of resection on outcome in pediatric non-rhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 34:672–675PubMed Blakely ML, Spurbeck WW, Pappo AS et al (1999) The impact of margin of resection on outcome in pediatric non-rhabdomyosarcoma soft tissue sarcoma. J Pediatr Surg 34:672–675PubMed
34.
Zurück zum Zitat Davis AM, Kandel RA, Wunder JS et al (1997) The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol 66:81–87PubMed Davis AM, Kandel RA, Wunder JS et al (1997) The impact of residual disease on local recurrence in patients treated by initial unplanned resection for soft tissue sarcoma of the extremity. J Surg Oncol 66:81–87PubMed
35.
Zurück zum Zitat Gupta GR, Yasko AW, Lewis VO et al (2009) Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer 115:3767–3773PubMed Gupta GR, Yasko AW, Lewis VO et al (2009) Risk of local recurrence after deltoid-sparing resection for osteosarcoma of the proximal humerus. Cancer 115:3767–3773PubMed
36.
Zurück zum Zitat Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A (2008) The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br 90:203–208PubMed Chandrasekar CR, Wafa H, Grimer RJ, Carter SR, Tillman RM, Abudu A (2008) The effect of an unplanned excision of a soft-tissue sarcoma on prognosis. J Bone Joint Surg Br 90:203–208PubMed
37.
Zurück zum Zitat Mavrogenis AF, Angelini A, Drago G, Merlino B, Ruggieri P (2013) Survival analysis of patients with chondrosarcomas of the pelvis. J Surg Oncol 108(1):19–27PubMed Mavrogenis AF, Angelini A, Drago G, Merlino B, Ruggieri P (2013) Survival analysis of patients with chondrosarcomas of the pelvis. J Surg Oncol 108(1):19–27PubMed
38.
Zurück zum Zitat World Health Organisation (1980) International classification of impairments, disabilities, and handicaps. World Health Organisation, Geneva World Health Organisation (1980) International classification of impairments, disabilities, and handicaps. World Health Organisation, Geneva
39.
Zurück zum Zitat Frink SJ, Rutledge J, Lewis VO, Lin PP, Yasko AW (2005) Favorable long-term results of prosthetic arthroplasty of the knee for distal femur neoplasms. Clin Orthop Relat Res 438:65–70PubMed Frink SJ, Rutledge J, Lewis VO, Lin PP, Yasko AW (2005) Favorable long-term results of prosthetic arthroplasty of the knee for distal femur neoplasms. Clin Orthop Relat Res 438:65–70PubMed
40.
Zurück zum Zitat Sim IW, Tse LF, Ek ET, Powell GJ, Choong PF (2007) Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee. Eur J Surg Oncol 33(6):796–802PubMed Sim IW, Tse LF, Ek ET, Powell GJ, Choong PF (2007) Salvaging the limb salvage: management of complications following endoprosthetic reconstruction for tumours around the knee. Eur J Surg Oncol 33(6):796–802PubMed
41.
Zurück zum Zitat Heisel C, Breusch SJ, Schmid G, Bernd L (2004) Lower limb salvage surgery with MUTARS endoprostheses: 2 to 7 year results. Acta Orthop Belg 70(2):142–147PubMed Heisel C, Breusch SJ, Schmid G, Bernd L (2004) Lower limb salvage surgery with MUTARS endoprostheses: 2 to 7 year results. Acta Orthop Belg 70(2):142–147PubMed
42.
Zurück zum Zitat O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft tissue reconstruction of the limbs: a randomized trial. Lancet 359:2235–2241PubMed O’Sullivan B, Davis AM, Turcotte R et al (2002) Preoperative versus postoperative radiotherapy in soft tissue reconstruction of the limbs: a randomized trial. Lancet 359:2235–2241PubMed
43.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Mercuri M (2011) Quality of life following limb salvage surgery for bone sarcomas. Expert Rev Pharmacoecon Outcomes Res 11(1):59–73PubMed Ruggieri P, Mavrogenis AF, Mercuri M (2011) Quality of life following limb salvage surgery for bone sarcomas. Expert Rev Pharmacoecon Outcomes Res 11(1):59–73PubMed
44.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167PubMed Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167PubMed
45.
Zurück zum Zitat Scully SP, Ghert MA, Zurakowski D et al (2002) Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84A(1):49–57 Scully SP, Ghert MA, Zurakowski D et al (2002) Pathologic fracture in osteosarcoma: prognostic importance and treatment implications. J Bone Joint Surg Am 84A(1):49–57
46.
Zurück zum Zitat Scully SP, Temple HT, O’Keefe RJ et al (1996) The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res 324:227–232PubMed Scully SP, Temple HT, O’Keefe RJ et al (1996) The surgical treatment of patients with osteosarcoma who sustain a pathologic fracture. Clin Orthop Relat Res 324:227–232PubMed
47.
Zurück zum Zitat Papagelopoulos PJ, Mavrogenis AF, Savvidou OD, Benetos IS, Galanis EC, Soucacos PN (2008) Pathological fractures in primary bone sarcomas. Injury 39(4):395–403PubMed Papagelopoulos PJ, Mavrogenis AF, Savvidou OD, Benetos IS, Galanis EC, Soucacos PN (2008) Pathological fractures in primary bone sarcomas. Injury 39(4):395–403PubMed
48.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167PubMed Ruggieri P, Mavrogenis AF, Casadei R, Errani C, Angelini A, Calabrò T, Pala E, Mercuri M (2010) Protocol of surgical treatment of long bone pathological fractures. Injury 41(11):1161–1167PubMed
49.
Zurück zum Zitat Mavrogenis AF, Pala E, Angelini A, Ferraro A, Ruggieri P (2013) Proximal tibial resections and reconstructions: clinical outcome of 225 patients. J Surg Oncol 107(4):335–342PubMed Mavrogenis AF, Pala E, Angelini A, Ferraro A, Ruggieri P (2013) Proximal tibial resections and reconstructions: clinical outcome of 225 patients. J Surg Oncol 107(4):335–342PubMed
50.
Zurück zum Zitat Mavrogenis AF, Angelini A, Pala E, Sakellariou VI, Ruggieri P, Papagelopoulos PJ (2012) Reconstruction of the extensor mechanism after major knee resection. Orthopedics 35(5):e672–e680PubMed Mavrogenis AF, Angelini A, Pala E, Sakellariou VI, Ruggieri P, Papagelopoulos PJ (2012) Reconstruction of the extensor mechanism after major knee resection. Orthopedics 35(5):e672–e680PubMed
51.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Pala E, Abdel-Mota’al M, Mercuri M (2012) Long term results of fixed-hinge megaprostheses in limb salvage for malignancy. Knee 19(5):543–549PubMed Ruggieri P, Mavrogenis AF, Pala E, Abdel-Mota’al M, Mercuri M (2012) Long term results of fixed-hinge megaprostheses in limb salvage for malignancy. Knee 19(5):543–549PubMed
52.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Guerra G, Mercuri M (2011) Preliminary results after reconstruction of bony defects of the proximal humerus with an allograft-resurfacing composite. J Bone Joint Surg Br 93(8):1098–1103PubMed Ruggieri P, Mavrogenis AF, Guerra G, Mercuri M (2011) Preliminary results after reconstruction of bony defects of the proximal humerus with an allograft-resurfacing composite. J Bone Joint Surg Br 93(8):1098–1103PubMed
53.
Zurück zum Zitat Canadell J, Forriol F, Cara JA (1994) Removal of metaphyseal bone tumours with preservation of the epiphysis. Physeal distraction before excision. J Bone Joint Surg Br 76:127–132PubMed Canadell J, Forriol F, Cara JA (1994) Removal of metaphyseal bone tumours with preservation of the epiphysis. Physeal distraction before excision. J Bone Joint Surg Br 76:127–132PubMed
54.
Zurück zum Zitat Mavrogenis AF, Soultanis K, Patapis P, Guerra G, Fabbri N, Ruggieri P, Papagelopoulos PJ (2012) Pelvic resections. Orthopedics 35(2):e232–e243PubMed Mavrogenis AF, Soultanis K, Patapis P, Guerra G, Fabbri N, Ruggieri P, Papagelopoulos PJ (2012) Pelvic resections. Orthopedics 35(2):e232–e243PubMed
55.
Zurück zum Zitat Enneking WF, Dunham WK (1978) Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am 60(6):731–746PubMed Enneking WF, Dunham WK (1978) Resection and reconstruction for primary neoplasms involving the innominate bone. J Bone Joint Surg Am 60(6):731–746PubMed
56.
Zurück zum Zitat Conrad EU III, Springfield D, Peabody TD (1998) Pelvis. In: Simon MA, Springfield D (eds) Surgery for bone and soft-tissue tumors. Lippincott-Raven Publishers, Philadelphia, pp 323–341 Conrad EU III, Springfield D, Peabody TD (1998) Pelvis. In: Simon MA, Springfield D (eds) Surgery for bone and soft-tissue tumors. Lippincott-Raven Publishers, Philadelphia, pp 323–341
57.
Zurück zum Zitat Fuchs B, Yaszemski MJ, Sim FH (2002) Combined posterior pelvis and lumbar spine resection for sarcoma. Clin Orthop Relat Res 397:12–18PubMed Fuchs B, Yaszemski MJ, Sim FH (2002) Combined posterior pelvis and lumbar spine resection for sarcoma. Clin Orthop Relat Res 397:12–18PubMed
58.
Zurück zum Zitat Mavrogenis AF, Soultanis K, Patapis P, Papagelopoulos PJ (2011) Anterior thigh flap extended hemipelvectomy and spinoiliac arthrodesis. Surg Oncol 20(4):e215–e221PubMed Mavrogenis AF, Soultanis K, Patapis P, Papagelopoulos PJ (2011) Anterior thigh flap extended hemipelvectomy and spinoiliac arthrodesis. Surg Oncol 20(4):e215–e221PubMed
59.
Zurück zum Zitat Senchenkov A, Moran SL, Petty PM, Knoetgen J 3rd, Clay RP, Bite U et al (2008) Predictors of complications and outcomes of external hemipelvectomy wounds: account of 160 consecutive cases. Ann Surg Oncol 15:355–363PubMed Senchenkov A, Moran SL, Petty PM, Knoetgen J 3rd, Clay RP, Bite U et al (2008) Predictors of complications and outcomes of external hemipelvectomy wounds: account of 160 consecutive cases. Ann Surg Oncol 15:355–363PubMed
60.
Zurück zum Zitat Campanacci M, Capanna R (1991) Pelvic resections: the Rizzoli Institute experience. Orthop Clin North Am 22(1):65–86PubMed Campanacci M, Capanna R (1991) Pelvic resections: the Rizzoli Institute experience. Orthop Clin North Am 22(1):65–86PubMed
61.
Zurück zum Zitat Karakousis C, Sugarbaker PH (2001) Sacrectomy. In: Malawer MM, Sugarbaker PH (eds) Musculoskeletal cancer surgery. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp 413–422 Karakousis C, Sugarbaker PH (2001) Sacrectomy. In: Malawer MM, Sugarbaker PH (eds) Musculoskeletal cancer surgery. Kluwer Academic Publishers, Dordrecht, The Netherlands, pp 413–422
62.
Zurück zum Zitat Rose PS, Yaszemski MJ, Dekutoski MB, Shives TC, Sim FH (2009) Classification of spinopelvic resections: oncologic and reconstructive implications. International society of limb salvage meeting, Boston Rose PS, Yaszemski MJ, Dekutoski MB, Shives TC, Sim FH (2009) Classification of spinopelvic resections: oncologic and reconstructive implications. International society of limb salvage meeting, Boston
63.
Zurück zum Zitat Kollender Y, Shabat S, Bickels J et al (2000) Internal hemipelvectomy for bone sarcomas in children and young adults: surgical considerations. Eur J Surg Oncol 26(4):398–404PubMed Kollender Y, Shabat S, Bickels J et al (2000) Internal hemipelvectomy for bone sarcomas in children and young adults: surgical considerations. Eur J Surg Oncol 26(4):398–404PubMed
64.
Zurück zum Zitat Ruggieri P, Mavrogenis AF, Pala E, Romantini M, Manfrini M, Mercuri M (2013) Outcome of expandable prostheses in children. J Pediatr Orthop 33(3):244–253PubMed Ruggieri P, Mavrogenis AF, Pala E, Romantini M, Manfrini M, Mercuri M (2013) Outcome of expandable prostheses in children. J Pediatr Orthop 33(3):244–253PubMed
65.
Zurück zum Zitat Mavrogenis AF, Papagelopoulos PJ, Coll-Mesa L, Pala E, Colangeli M, Manfrini M, Ruggieri P (2012) Expandable tumor prostheses in children. J BUON 17(1):9–15PubMed Mavrogenis AF, Papagelopoulos PJ, Coll-Mesa L, Pala E, Colangeli M, Manfrini M, Ruggieri P (2012) Expandable tumor prostheses in children. J BUON 17(1):9–15PubMed
66.
Zurück zum Zitat Neel MD, Wilkins RM, Rao BN et al (2003) Early multicenter experience with a noninvasive expandable prosthesis. Clin Orthop Relat Res 415:72–81PubMed Neel MD, Wilkins RM, Rao BN et al (2003) Early multicenter experience with a noninvasive expandable prosthesis. Clin Orthop Relat Res 415:72–81PubMed
67.
Zurück zum Zitat Yoshida Y, Iwata S, Ueda T et al (2008) Current state of extendable prostheses for the lower limb in Japan. Surg Oncol 17:65–71PubMed Yoshida Y, Iwata S, Ueda T et al (2008) Current state of extendable prostheses for the lower limb in Japan. Surg Oncol 17:65–71PubMed
68.
Zurück zum Zitat Belthur MV, Grimer RJ, Suneja R et al (2003) Extensible endoprostheses for bone tumors of the proximal femur in children. J Pediatr Orthop 23:230–235PubMed Belthur MV, Grimer RJ, Suneja R et al (2003) Extensible endoprostheses for bone tumors of the proximal femur in children. J Pediatr Orthop 23:230–235PubMed
69.
Zurück zum Zitat Henderson ER, Pepper AM, Marulanda GA et al (2010) What is the emotional acceptance after limb salvage with an expandable prosthesis? Clin Orthop Relat Res 468:2933–2938PubMedCentralPubMed Henderson ER, Pepper AM, Marulanda GA et al (2010) What is the emotional acceptance after limb salvage with an expandable prosthesis? Clin Orthop Relat Res 468:2933–2938PubMedCentralPubMed
70.
Zurück zum Zitat Eckardt JJ, Safran MR, Eilber FR et al (1993) Expandable endoprosthetic reconstruction of the skeletally immature after malignant bone tumor resection. Clin Orthop Relat Res 297:188–202PubMed Eckardt JJ, Safran MR, Eilber FR et al (1993) Expandable endoprosthetic reconstruction of the skeletally immature after malignant bone tumor resection. Clin Orthop Relat Res 297:188–202PubMed
71.
Zurück zum Zitat Schindler OS, Cannon SR, Briggs TW et al (1998) Use of extendable total femoral replacements in children with malignant bone tumors. Clin Orthop Relat Res 357:157–170PubMed Schindler OS, Cannon SR, Briggs TW et al (1998) Use of extendable total femoral replacements in children with malignant bone tumors. Clin Orthop Relat Res 357:157–170PubMed
72.
Zurück zum Zitat Wilkins RM, Soubeiran A (2001) The Phenix expandable prosthesis: early American experience. Clin Orthop Relat Res 382:51–58PubMed Wilkins RM, Soubeiran A (2001) The Phenix expandable prosthesis: early American experience. Clin Orthop Relat Res 382:51–58PubMed
73.
Zurück zum Zitat Saghieh S, Abboud MR, Muwakkit SA et al (2010) Seven-year experience of using repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer 55:457–463PubMed Saghieh S, Abboud MR, Muwakkit SA et al (2010) Seven-year experience of using repiphysis expandable prosthesis in children with bone tumors. Pediatr Blood Cancer 55:457–463PubMed
74.
Zurück zum Zitat Cheong D, Letson GD (2011) Computer-assisted navigation and musculoskeletal sarcoma surgery. Cancer Control 18(3):171–176PubMed Cheong D, Letson GD (2011) Computer-assisted navigation and musculoskeletal sarcoma surgery. Cancer Control 18(3):171–176PubMed
76.
Zurück zum Zitat Mavrogenis AF, Savvidou OD, Mimidis G, Papanastasiou J, Koulalis D, Demertzis N, Papagelopoulos PJ (2013) Computer-assisted navigation in orthopedic surgery. Orthopedics 36(8):631–642PubMed Mavrogenis AF, Savvidou OD, Mimidis G, Papanastasiou J, Koulalis D, Demertzis N, Papagelopoulos PJ (2013) Computer-assisted navigation in orthopedic surgery. Orthopedics 36(8):631–642PubMed
77.
Zurück zum Zitat Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341:342–352PubMed Arndt CA, Crist WM (1999) Common musculoskeletal tumors of childhood and adolescence. N Engl J Med 341:342–352PubMed
78.
Zurück zum Zitat Bielack SS, Machatschek JN, Flege S, Jurgens H (2004) Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother 5:1243–1256PubMed Bielack SS, Machatschek JN, Flege S, Jurgens H (2004) Delaying surgery with chemotherapy for osteosarcoma of the extremities. Expert Opin Pharmacother 5:1243–1256PubMed
79.
Zurück zum Zitat Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519PubMed Bernstein M, Kovar H, Paulussen M et al (2006) Ewing’s sarcoma family of tumors: current management. Oncologist 11:503–519PubMed
80.
Zurück zum Zitat Grimer RJ, Cannon SR, Taminiau AM et al (2003) Osteosarcoma over the age of forty. Eur J Cancer 39:157–163PubMed Grimer RJ, Cannon SR, Taminiau AM et al (2003) Osteosarcoma over the age of forty. Eur J Cancer 39:157–163PubMed
81.
Zurück zum Zitat Scurr M, Judson I (2006) How to treat the Ewing’s family of sarcomas in adult patients. Oncologist 11:65–72PubMed Scurr M, Judson I (2006) How to treat the Ewing’s family of sarcomas in adult patients. Oncologist 11:65–72PubMed
82.
Zurück zum Zitat Bacci G, Picci P, Ferrari S et al (1998) Neoadjuvant chemotherapy for Ewing’s sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase—results of two sequential studies. Cancer 82:1174–1183PubMed Bacci G, Picci P, Ferrari S et al (1998) Neoadjuvant chemotherapy for Ewing’s sarcoma of bone: no benefit observed after adding ifosfamide and etoposide to vincristine, actinomycin, cyclophosphamide, and doxorubicin in the maintenance phase—results of two sequential studies. Cancer 82:1174–1183PubMed
83.
Zurück zum Zitat Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing’s Sarcoma Study CESS 86. J Clin Oncol 19:1818–1829PubMed Paulussen M, Ahrens S, Dunst J et al (2001) Localized Ewing tumor of bone: final results of the cooperative Ewing’s Sarcoma Study CESS 86. J Clin Oncol 19:1818–1829PubMed
84.
Zurück zum Zitat Grier HE, Krailo MD, Tarbell NJ et al (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694–701PubMed Grier HE, Krailo MD, Tarbell NJ et al (2003) Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med 348:694–701PubMed
85.
Zurück zum Zitat Ozaki T, Flege S, Kevric M et al (2003) Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 21:334–341PubMed Ozaki T, Flege S, Kevric M et al (2003) Osteosarcoma of the pelvis: experience of the Cooperative Osteosarcoma Study Group. J Clin Oncol 21:334–341PubMed
86.
Zurück zum Zitat DeLaney TF, Park L, Goldberg SI et al (2005) Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61:492–498PubMed DeLaney TF, Park L, Goldberg SI et al (2005) Radiotherapy for local control of osteosarcoma. Int J Radiat Oncol Biol Phys 61:492–498PubMed
87.
Zurück zum Zitat Patel S, DeLaney TF (2008) Advanced-technology radiation therapy for bone sarcomas. Cancer Control 15(1):21–37PubMed Patel S, DeLaney TF (2008) Advanced-technology radiation therapy for bone sarcomas. Cancer Control 15(1):21–37PubMed
88.
Zurück zum Zitat Hug EB (2001) Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy. Neurosurg Focus 10:E11PubMed Hug EB (2001) Review of skull base chordomas: prognostic factors and long-term results of proton-beam radiotherapy. Neurosurg Focus 10:E11PubMed
89.
Zurück zum Zitat Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175(suppl 2):57–63PubMed Munzenrider JE, Liebsch NJ (1999) Proton therapy for tumors of the skull base. Strahlenther Onkol 175(suppl 2):57–63PubMed
90.
Zurück zum Zitat Ewing J (1972) Classics in oncology. Diffuse endothelioma of bone. James Ewing. Proceedings of the New York Pathological Society, 1921. CA Cancer J Clin 22: 95–98 Ewing J (1972) Classics in oncology. Diffuse endothelioma of bone. James Ewing. Proceedings of the New York Pathological Society, 1921. CA Cancer J Clin 22: 95–98
91.
Zurück zum Zitat Sailer SL (1997) The role of radiation therapy in localized Ewing’s sarcoma. Semin Radiat Oncol 7:225–235PubMed Sailer SL (1997) The role of radiation therapy in localized Ewing’s sarcoma. Semin Radiat Oncol 7:225–235PubMed
92.
Zurück zum Zitat Park L, Delaney TF, Liebsch NJ et al (2006) Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 65:1514–1521PubMed Park L, Delaney TF, Liebsch NJ et al (2006) Sacral chordomas: impact of high-dose proton/photon-beam radiation therapy combined with or without surgery for primary versus recurrent tumor. Int J Radiat Oncol Biol Phys 65:1514–1521PubMed
93.
Zurück zum Zitat Lee CT, Bilton SD, Famiglietti RM et al (2005) Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63:362–372PubMed Lee CT, Bilton SD, Famiglietti RM et al (2005) Treatment planning with protons for pediatric retinoblastoma, medulloblastoma, and pelvic sarcoma: how do protons compare with other conformal techniques? Int J Radiat Oncol Biol Phys 63:362–372PubMed
94.
Zurück zum Zitat DeLaney TF, Liebsch NJ, Spiro IJ et al (2006) Proton radiotherapy for spine and paraspinal sarcomas. Int J Radiat Oncol Biol Phys 66:S115–S116 DeLaney TF, Liebsch NJ, Spiro IJ et al (2006) Proton radiotherapy for spine and paraspinal sarcomas. Int J Radiat Oncol Biol Phys 66:S115–S116
95.
Zurück zum Zitat Yock T, Schneider R, Friedmann A et al (2005) Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 63:1161–1168PubMed Yock T, Schneider R, Friedmann A et al (2005) Proton radiotherapy for orbital rhabdomyosarcoma: clinical outcome and a dosimetric comparison with photons. Int J Radiat Oncol Biol Phys 63:1161–1168PubMed
96.
Zurück zum Zitat Ozaki T, Hillmann A, Rübe C et al (1997) The impact of intraoperative brachytherapy on surgery of Ewing’s sarcoma. J Cancer Res Clin Oncol 123:53–56PubMed Ozaki T, Hillmann A, Rübe C et al (1997) The impact of intraoperative brachytherapy on surgery of Ewing’s sarcoma. J Cancer Res Clin Oncol 123:53–56PubMed
97.
Zurück zum Zitat Linstadt DE, Castro JR, Phillips TL (1991) Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys 20:761–769PubMed Linstadt DE, Castro JR, Phillips TL (1991) Neon ion radiotherapy: results of the phase I/II clinical trial. Int J Radiat Oncol Biol Phys 20:761–769PubMed
98.
Zurück zum Zitat Kamada T, Tsujii H, Tsuji H et al (2002) Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 20:4466–4471PubMed Kamada T, Tsujii H, Tsuji H et al (2002) Efficacy and safety of carbon ion radiotherapy in bone and soft tissue sarcomas. J Clin Oncol 20:4466–4471PubMed
99.
Zurück zum Zitat Schulz-Ertner D, Nikoghosyan A, Thilmann C et al (2004) Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 58:631–640PubMed Schulz-Ertner D, Nikoghosyan A, Thilmann C et al (2004) Results of carbon ion radiotherapy in 152 patients. Int J Radiat Oncol Biol Phys 58:631–640PubMed
100.
Zurück zum Zitat Anderson PM, Wiseman GA, Dispenzieri A et al (2002) High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 20:189–196PubMed Anderson PM, Wiseman GA, Dispenzieri A et al (2002) High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases. J Clin Oncol 20:189–196PubMed
101.
Zurück zum Zitat Anderson PM, Wiseman GA, Erlandson L et al (2005) Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clin Cancer Res 11(19 Pt 1):6895–6900PubMed Anderson PM, Wiseman GA, Erlandson L et al (2005) Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma. Clin Cancer Res 11(19 Pt 1):6895–6900PubMed
102.
Zurück zum Zitat Kager L, Zoubek A, Potschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21:2011–2018PubMed Kager L, Zoubek A, Potschger U et al (2003) Primary metastatic osteosarcoma: presentation and outcome of patients treated on neoadjuvant Cooperative Osteosarcoma Study Group protocols. J Clin Oncol 21:2011–2018PubMed
103.
Zurück zum Zitat Paulussen M, Ahrens S, Burdach S et al (1998) Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9:275–281PubMed Paulussen M, Ahrens S, Burdach S et al (1998) Primary metastatic (stage IV) Ewing tumor: survival analysis of 171 patients from the EICESS studies. European Intergroup Cooperative Ewing Sarcoma Studies. Ann Oncol 9:275–281PubMed
104.
Zurück zum Zitat Kempf-Bielack B, Bielack SS, Jürgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 20:559–568 Kempf-Bielack B, Bielack SS, Jürgens H et al (2005) Osteosarcoma relapse after combined modality therapy: an analysis of unselected patients in the Cooperative Osteosarcoma Study Group (COSS). J Clin Oncol 20:559–568
105.
Zurück zum Zitat Briccoli A, Rocca M, Ferrari S et al (2004) Surgery for lung metastases in Ewing’s sarcoma of bone. Eur J Surg Oncol 30:63–67PubMed Briccoli A, Rocca M, Ferrari S et al (2004) Surgery for lung metastases in Ewing’s sarcoma of bone. Eur J Surg Oncol 30:63–67PubMed
106.
Zurück zum Zitat Fröhlich B, Ahrens S, Burdach S, Klingebiel T, Ladenstein R, Paulussen M, Zoubek A, Jürgens H (1999) High-dosage chemotherapy in primary metastasized and relapsed Ewing’s sarcoma. Klin Padiatr 211(4):284–290PubMed Fröhlich B, Ahrens S, Burdach S, Klingebiel T, Ladenstein R, Paulussen M, Zoubek A, Jürgens H (1999) High-dosage chemotherapy in primary metastasized and relapsed Ewing’s sarcoma. Klin Padiatr 211(4):284–290PubMed
107.
Zurück zum Zitat Mavrogenis AF, Pala E, Romantini M, Guerra G, Romagnoli C, Maccauro G, Ruggieri P (2011) Side effects of radiation in musculoskeletal oncology: clinical evaluation of radiation-induced fractures. Int J Immunopathol Pharmacol 24(1 Suppl 2):29–37PubMed Mavrogenis AF, Pala E, Romantini M, Guerra G, Romagnoli C, Maccauro G, Ruggieri P (2011) Side effects of radiation in musculoskeletal oncology: clinical evaluation of radiation-induced fractures. Int J Immunopathol Pharmacol 24(1 Suppl 2):29–37PubMed
108.
Zurück zum Zitat Mavrogenis AF, Papagelopoulos PJ, Romantini M, Angelini A, Ruggieri P (2010) Side effects of chemotherapy in musculoskeletal oncology. J Long Term Eff Med Implants 20(1):1–12PubMed Mavrogenis AF, Papagelopoulos PJ, Romantini M, Angelini A, Ruggieri P (2010) Side effects of chemotherapy in musculoskeletal oncology. J Long Term Eff Med Implants 20(1):1–12PubMed
109.
Zurück zum Zitat Mavrogenis AF, Papagelopoulos PJ, Romantini M, Guerra G, Ruggieri P (2009) Side effects of radiation in musculoskeletal oncology. J Long Term Eff Med Implants 19(4):287–304PubMed Mavrogenis AF, Papagelopoulos PJ, Romantini M, Guerra G, Ruggieri P (2009) Side effects of radiation in musculoskeletal oncology. J Long Term Eff Med Implants 19(4):287–304PubMed
110.
Zurück zum Zitat Casadei R, Mavrogenis AF, De Paolis M, Ruggieri P (2013) Two-stage, combined, three-level en bloc spondylectomy for a recurrent post-radiation sarcoma of the lumbar spine. Eur J Orthop Surg Traumatol 23(Suppl 1):93–100 Casadei R, Mavrogenis AF, De Paolis M, Ruggieri P (2013) Two-stage, combined, three-level en bloc spondylectomy for a recurrent post-radiation sarcoma of the lumbar spine. Eur J Orthop Surg Traumatol 23(Suppl 1):93–100
Metadaten
Titel
State-of-the-art approach for bone sarcomas
verfasst von
Andreas F. Mavrogenis
Andrea Angelini
Christos Vottis
Emanuela Palmerini
Eugenio Rimondi
Giuseppe Rossi
Panayiotis J. Papagelopoulos
Pietro Ruggieri
Publikationsdatum
01.01.2015
Verlag
Springer Paris
Erschienen in
European Journal of Orthopaedic Surgery & Traumatology / Ausgabe 1/2015
Print ISSN: 1633-8065
Elektronische ISSN: 1432-1068
DOI
https://doi.org/10.1007/s00590-014-1468-2

Weitere Artikel der Ausgabe 1/2015

European Journal of Orthopaedic Surgery & Traumatology 1/2015 Zur Ausgabe

Arthropedia

Grundlagenwissen der Arthroskopie und Gelenkchirurgie. Erweitert durch Fallbeispiele, Videos und Abbildungen. 
» Jetzt entdecken

Update Orthopädie und Unfallchirurgie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.